COMP <GO>
CLYM vs IRWD // EV/EBITDA & P/E VALUATION
Climb Bio Inc. (NASDAQ) VS. Ironwood Pharmaceuticals Inc. (Class A) (NASDAQ) • 15-METRIC TALLY: CLYM 1
— IRWD 4
■ METRIC PARITY
LAST: $10.33 (+2.08%) • MKT CAP: $593.3M
valuation
—
LAST: $3.62 (+0.28%) • MKT CAP: $598.2M
valuation
3.9x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLYM VS. IRWD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLYM | IRWD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 85.00% | -120.00 | IRWD | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 3.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -9.19% | 21.23% | -30.42 | IRWD | /fcf-yield <GO> |
| Operating Margin | — | 33.30% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 8.10% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -15.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | IRWD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.1 | 40.5 | +3.60 | CLYM | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 23.2x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $593.3M | $598.2M | -$4.9M | IRWD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLYM REV | IRWD REV | CLYM GROSS % | IRWD GROSS % | CLYM FCF | IRWD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $296.2M | — | — | -$54.5M | $127.0M |
| FY 2024 | $0 | $351.4M | — | — | -$15.6M | $103.4M |
| FY 2023 | $0 | $442.7M | — | — | -$20.6M | $183.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLYM // BETA —
IRWD // BETA —